Global commercial-stage biopharmaceutical company developing and commercializing precision medicines for rare neuroendocrine diseases, including MC4R pathway disorders, rare genetic obesity, acquired hypothalamic obesity, and congenital hyperinsulinism
Global commercial-stage biopharmaceutical company developing and commercializing precision medicines for rare neuroendocrine diseases, including MC4R pathway disorders, rare genetic obesity, acquired hypothalamic obesity, and congenital hyperinsulinism.